SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Human Genome Sciences, Inc. (HGSI) -- Ignore unavailable to you. Want to Upgrade?

To: Steven Rachbach who wrote (569)3/13/2001 7:06:23 PM
From: Elmer  Read Replies (1) | Respond to of 1127
 
The Motley Fool has a series of good posts on Hgsi starting with
boards.fool.com



To: Steven Rachbach who wrote (569)5/6/2001 11:46:50 AM
From: John Lacelle  Read Replies (1) | Respond to of 1127
 
Steve,

That research has been around for a long time. In fact, the first
Doctor to use a monoclonal antibody therapy for cancer was right
here in Santa Barbara back in the 1980's. However, there are some
drawbacks to this treatment and it has not proven to be the panacea
to cancer that we thought it would be. Again, breast cancer is best
treated with radiation and chemotheraphy, and surgery.

-John


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News